Dexamethasone therapy in COVID‐19 patients: implications and guidance for the management of blood glucose in people with and without diabetes-Reference-Cited by-同舟云学术

Dexamethasone therapy in COVID‐19 patients: implications and guidance for the management of blood glucose in people with and without diabetes

Published:2020-09-21 Issue:1 Volume:38 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Rayman G.¹^ORCID,Lumb A. N.²,Kennon B.³,Cottrell C.⁴,Nagi D.⁵,Page E.⁶^ORCID,Voigt D.⁷,Courtney H. C.⁸,Atkins H.⁹,Higgins K.⁹,Platts J.¹⁰,Dhatariya K.¹¹^ORCID,Patel M.¹²^ORCID,Newland‐Jones P.¹²,Narendran P.¹³,Kar P.¹⁴,Burr O.¹⁵,Thomas S.¹⁶,Stewart R.¹⁷^ORCID

Affiliation:

1. The Ipswich Diabetes Centre East Suffolk and North Essex NHS Foundation Trust Colchester

2. Churchill HospitalOxford University Hospitals NHS Foundation Trust Oxford

3. Department of Diabetes Queen Elizabeth University Hospital Glasgow

4. Swansea Bay University Health Board Port Talbot

5. Mid Yorkshire Hospital NHS Trust Wakefield

6. Diabetes Centre Ipswich Hospital NHS Trust Ipswich

7. Ninewells HospitalNHS Tayside Dundee

8. Belfast Health and Social Care Trust Belfast

9. University Hospitals of Leicester NHS Trust Leicester

10. Cardiff and Vale University Health Board Cardiff

11. Diabetes Centre Norfolk & Norwich University Hospital NHS Trust Norwich

12. University Hospital Southampton NHS Foundation Trust Southampton

13. Queen Elizabeth Hospital Birmingham Birmingham

14. NHS Diabetes Programme NHS England

15. Diabetes UK

16. Diabetes Centre King’s College Hospital London

17. Gladstone Centre Wrexham Maelor Hospital Wrexham UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14378

Reference5 articles.

1. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies ( JBDS ) for Inpatient Care group

2. Practical recommendations for the management of diabetes in patients with COVID-19

3. Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID‐19 pandemic

4. Maintaining glycaemic control during high‐dose prednisolone administration for hyperemesis gravidarum in type 1 diabetes;Dashora UK;Diabet Med,2003

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of diabetes on COVID-19 and glucocorticoids on patients with COVID-19 and diabetes during the Omicron variant epidemic: a multicenter retrospective cohort study in South China;BMC Infectious Diseases;2024-07-18

2. Continuous glucose monitoring profile in COVID-19 patients with and without diabetes receiving methylprednisolone;Endocrine;2024-05-31

3. Glucocorticoid-Induced Hyperglycemia: A Neglected Problem;Endocrinology and Metabolism;2024-04-30

4. Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus;World Journal of Diabetes;2024-04-15

5. The Impact of Insulin Degludec on Glucocorticoid-Induced Hyperglycemia in Patients with Diabetes and COVID-19 Infection;Journal of Diabetology;2024-04